Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (161-170 of 270) with videos related to

Pageof 27
Sort By:
Nucleic Acids Research|February 2, 2023
SMAD3 promotes expression and activity of the androgen receptor in prostate cancerHee-Young Jeon, Majid Pornour, Hyunju Ryu, et al.
Journal of Clinical Pathology|January 30, 2007
Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancersAshish B Rajput, Melinda A Miller, Alessandro De Luca, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2022
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancerThi Khanh Le, Chaïma Cherif, Kenneth Omabe, et al.
The Journal of Clinical Investigation|December 4, 2025
Non-canonical functions of UGT2B17 promote castrate-resistant prostate cancer progressionTingting Feng, Ning Xie, Lin Gao, et al.
The Prostate|September 8, 2007
Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expressionChang Xu, Lynn F Graf, Ladan Fazli, et al.
EMBO Molecular Medicine|April 13, 2015
Divergent androgen regulation of unfolded protein response pathways drives prostate cancerXia Sheng, Yke Jildouw Arnoldussen, Margrethe Storm, et al.
Nature Communications|March 22, 2021
A noncanonical AR addiction drives enzalutamide resistance in prostate cancerYundong He, Ting Wei, Zhenqing Ye, et al.
NMR in Biomedicine|November 11, 2014
MR elastography and diffusion-weighted imaging of ex vivo prostate cancer: quantitative comparison to histopathologyRamin S Sahebjavaher, Guy Nir, Louis O Gagnon, et al.
Journal of the National Cancer Institute|September 21, 2013
Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor developmentQian Wang, Jessamy Tiffen, Charles G Bailey, et al.
ACS Central Science|June 1, 2022
Durable Surfaces from Film-Forming Silver Assemblies for Long-Term Zero Bacterial Adhesion without ToxicityHossein Yazdani-Ahmadabadi, Demian F Felix, Kai Yu, et al.
Pageof 27

Showing results (161-170 of 270) with videos related to

Sort By:
Pageof 27
Nucleic Acids Research|February 2, 2023
SMAD3 promotes expression and activity of the androgen receptor in prostate cancerHee-Young Jeon, Majid Pornour, Hyunju Ryu, et al.
Journal of Clinical Pathology|January 30, 2007
Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancersAshish B Rajput, Melinda A Miller, Alessandro De Luca, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2022
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancerThi Khanh Le, Chaïma Cherif, Kenneth Omabe, et al.
The Journal of Clinical Investigation|December 4, 2025
Non-canonical functions of UGT2B17 promote castrate-resistant prostate cancer progressionTingting Feng, Ning Xie, Lin Gao, et al.
The Prostate|September 8, 2007
Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expressionChang Xu, Lynn F Graf, Ladan Fazli, et al.
EMBO Molecular Medicine|April 13, 2015
Divergent androgen regulation of unfolded protein response pathways drives prostate cancerXia Sheng, Yke Jildouw Arnoldussen, Margrethe Storm, et al.
Nature Communications|March 22, 2021
A noncanonical AR addiction drives enzalutamide resistance in prostate cancerYundong He, Ting Wei, Zhenqing Ye, et al.
NMR in Biomedicine|November 11, 2014
MR elastography and diffusion-weighted imaging of ex vivo prostate cancer: quantitative comparison to histopathologyRamin S Sahebjavaher, Guy Nir, Louis O Gagnon, et al.
Journal of the National Cancer Institute|September 21, 2013
Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor developmentQian Wang, Jessamy Tiffen, Charles G Bailey, et al.
ACS Central Science|June 1, 2022
Durable Surfaces from Film-Forming Silver Assemblies for Long-Term Zero Bacterial Adhesion without ToxicityHossein Yazdani-Ahmadabadi, Demian F Felix, Kai Yu, et al.
Pageof 27